| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 18, 2018 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,307 | -- | 14,283 | |
| Jul 18, 2018 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,539 | -- | 18,036 | |
| Jul 18, 2018 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,276 | -- | 11,276 | |
| Jul 18, 2018 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,079 | -- | 7,079 | |
| Jul 18, 2018 | Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 17,469 | -- | 129,286 | |
| Jul 18, 2018 | Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 55,651 | -- | 55,651 | |
| Jul 18, 2018 | Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 34,938 | -- | 34,938 | |
| Jul 18, 2018 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,307 | -- | 68,489 | |
| Jul 18, 2018 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,307 | -- | 73,209 | |
| Jul 18, 2018 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,307 | -- | 55,124 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.